Oral hypoglycemic agents:
Comparative Review of Oral Hypoglycemic Agents in Adults
... of oral hypoglycemic agents – glitazones, DPP-4 inhibitors, alpha-glucosidase inhibitors and meglitinides versus sulfonylureas and metformin using GRADE methodology in Section IV and in Tables 6 ...
37
Oral hypoglycemic agents: do the ends justify the means?
... Historically, insulin has been the recommended treat- ment for GDM in the U.S. when dietary and lifestyle measures have failed. Today, randomized controlled tri- als support the efficacy and short-term safety of glybur- ...
10
Patterns of Adherence to Oral Hypoglycemic Agents: Patterns, Correlates, and Outcomes
... Prior work has found that neighborhood residence is associated with medication adherence (Billimek & August, 2013; Groenewegen et al., 1999; Merlo et al., 2003) and other self-care behaviors (Adams et al., 2013; ...
78
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
... Fax +44 1382 383 598 email [email protected] Abstract: Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Oral ...
13
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
... The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral ...
10
A STUDY ON DRUG UTILIZATION OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS
... of oral hypoglycemic agents in Type-2 diabetic ...with oral hypoglycemic agents were used for the ...of oral hypoglycemic agents as well as individual drugs ...
5
Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents
... . Oral hypoglycemic agents Introduction Nonadherence to prescribed medication has been identified to be a major source of suboptimal management of several chronic diseases [1 – ...
10
Adverse perinatal outcome in diabetic mother treated with oral hypoglycemic agents vs insulin
... INTRODUCTION Worldwide prevalence of diabetes mellitus is increasing and gestational diabetes mellitus (GDM) constitutes 88% of all cases of diabetes in pregnancy. 1 Incidence of GDM is significantly greater (15%) in ...
6
PHARMACOECONOMICAL EVALUATION OF ORAL HYPOGLYCEMIC AGENTS FOR TYPE 2 DIABETES MELLITUS IN A MULTISPECIALITY HOSPITAL
... T. Tamilselvan * , T. Kumutha, Amrita Lekshmi V., Anju C. James, Juliya S. Reji and Namitha Cheriyan Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalyam - 637205, India. ABSTRACT: The ...
6
IDENTIFICATION, ASSESSMENT AND ANALYSING THE COST EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS FOR PHARMACOECONOMIC EVALUATION IN A TERTIARY CARE TEACHING HOSPITAL
... all oral hypoglycemic agents, the most cost-effective drug or combination in the hospital was ...prescribed oral hypoglycemic monotherapy and Metformin + Glimepiride (2mg+500mg) was the ...
14
Neighborhood Social Environment and Patterns of Adherence to Oral Hypoglycemic Agents among Patients with Type 2 Diabetes Mellitus
... Measurement Strategy Patient Characteristics— Potential study patients were screened for cognitive impairment using the MMSE, a short standardized mental status examination widely employed for clinical and research ...
17
Adverse Effects of Oral Hypoglycemic Agents and Adherence to them among Patients with Type 2 Diabetes Mellitus in Nepal
... population growth, increasing prevalence of obesity and inactivity, which is estimated to affect at least 300 million people worldwide by 2025.[2] The condition can be classified into two types Type 1 and Type 2 DM ...
7
A STUDY ON DRUG UTILIZATION PATTERN OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL
... of oral hypoglycemic agents in type- 2 diabetic patients of a tertiary care teaching ...prescribed oral hypoglycemic agents are Metformin in mono and combination ...
8
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
... (pioglitazone, rosiglitazone), insulin and other oral hypoglycemic agents (chlorpropamide, gliclazide, tolbutamide, glimepiride, sitagliptin, saxagliptin, nateglinide, repaglinide). The cumulative ...
21
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
... Ultimately, the net impact of glyburide on tumour cells remains poorly understood. 15 The current literature evaluat- ing the impact of glyburide (and sulfonylureas in general) on cancer incidence and cancer-related ...
8
SAFETY OF INSULIN ADD ON THERAPY AND ORAL HYPOGLYCEMIC AGENTS (OHGAs) POLYPHARMACY IN TYPE II DIABETES PATIENTS A PROSPECTIVE OBSERVATIONAL STUDY
... and Oral Hypoglycemic Agents (OHGAs) polypharmacy and to promote safe use of insulin and OHGAs in Type II Diabetes patients, through patient counseling by Clinical pharmacist at Government General ...
14
INCIDENCE OF ADVERSE DRUG REACTIONS AND DRUG INTERACTIONS OF ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETIC PATIENTS AT GUWAHATHI MEDICAL COLLEGE HOSPITAL
... To determine the incidence of adverse drug reactions and drug inter- actions due to oral hypoglycemic agents in patients suffering from type 2 diabetes. Methodology: Prior to the conduction of study, ...
8
Utilization Pattern of Oral Hypoglycemic Agents for Diabetes Mellitus Type 2 Patients Attending Out Patient Department at a University Hospital in New Delhi
... Abstract Diabetes mellitus is the chronic disorder emerging as a major world health problem which in- creases the rate of morbidity and mortality. The aim of the present study was to ascertain patterns of prescription of ...
10
Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City
... In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed direct health care cost. Diabetes is Mexico’s leading cause of death. Purpose: To evaluate the ...
9
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
... Because this study was a retrospective analysis of OHA utilization patterns using pharmacy administrative claims from a large pharmacy benefit manager, it is im- portant to recognize some inherent study limitations. This ...
5